Primary Outcome Variables. The primary goal of this study is to [***] the [***], both [***] and [***], with [***] are [***] in a [***]. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Primary Outcome Variables. To evaluate the effect of presence and height of baseline PED at weeks 24 and 52. Proportion of patients with resolution of PED at weeks 24 and 52.
